Cycloheximide inhibits neurotoxic responses induced by kainic acid in mice

Brain Research Bulletin

Volumn 61, Issue 1, 2003, Pages 99-107

  Lee, Han Kyu ^a   Choi, Seong Soo ^a   Han, Ki Jung ^a   Han, Eun Jung ^a   Suh, Hong Won ^a  

^a Hallym University   (South Korea)

Author keywords

CaMK II; Cycloheximide; Excitotoxicity; Kainic acid; MAPK; Microglia

Indexed keywords

CYCLOHEXIMIDE; KAINIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; OXYGENASE; OXYGENASE 42; PROTEIN KINASE (CALCIUM,CALMODULIN) II; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DEATH; CELL STRUCTURE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FUNCTION TEST; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MEMORY; MEMORY DISORDER; MICROGLIA; MOUSE; NEUROTOXICITY; NONHUMAN; PASSIVE AVOIDANCE TEST; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL;

EID: 0038548998     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(03)00078-9     Document Type: Article

References (52)

1. Baik E.J., Kim E.J., Lee S.H., Moon C. Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus. Brain Res. 843:1999;118-129.
2. Ben-Ari Y. Limbic seizure and brain damage produce by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 14:1983;375-403.
3. Bohman D., Bos T.J., Admon A., Nishimura T., Vogt P.K., Tjian R. Human protooncogene c-jun encodes a DNA-binding protein with structural and functional properties of transcription factor AP-1. Science. 238:1987;1386-1392.
4. Braun A.P., Schulman H. The multifunctional calcium/calmodulin-dependent protein kinase: from form to function. Annu. Rev. Physiol. 57:1995;417-445.
5. Cazevieille C., Osborne N.N. Retinal neurones containing kainate receptors are influenced by exogenous kainate and ischaemia while neurones lacking these receptors are not - melatonin counteracts the effects of ischaemia and kainite. Brain Res. 755:1997;91-100.
6. Chen Y.-R., Wang W., Kong T., Tan T.-H. Molecular mechanism of c-Jun N-terminal kinase-mediated apoptosis induced by anticarcinogenic isothiocyanates. J. Biol. Chem. 273:1998;1769-1775.
7. Cohen D.R., Curran T. fra-I: a serum-inducible, cellular immediate-early gene that encodes a Fos-related antigen. Mol. Cell. Biol. 8:1988;2063-2069.
8. Crepel V., Represa A., Beaudoin M., Ben-Ari Y. Hippocampal damage induced by ischemia and intra-amygdaloid kainate injection: effect on N-methyl-D-aspartate, N-(1-[2-thienyl]cyclohexyl)piperidine and glycine binding sites. Neuroscience. 31:1989;605-612.
9. Csernansky J.G., Csernansky C.A., Kogelman L., Montgomery E.M., Bardgett M.E. Progressive neurodegeneration after intracerebroventricular kainic acid administration in rats: implications for schizophrenia? Biol. Psychiatry. 44:1998;1143-1150.
10. DeCoster M.A., Mukherjee P.K., Davis R.J., Bazan N.G. Platelet-activating factor is a downstream messenger of kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons. J. Neurosci. Res. 53:1998;297-303.
11. R.S. Feldman, J.S. Meyer, L.F. Quenzer, Principles of Neuropsychopharmacology, Sinauer, Sunderland, MA, 1997.
12. Flood J.F., Baker M.L., Davis J.L. Modulation of memory processing by glutamic acid receptor agonists and antagonists. Brain Res. 521:1990;197-202.
13. Flood D.G., Finn J.P., Walton K.M., Dionne C.A., Contreras P.C., Miller M.S., Bhat R.V. Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system. J. Comp. Neurol. 398:1998;373-392.
14. Giusti P., Lipartiti M., Franceschini D., Schiavo N., Floreani M., Manev H. Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB J. 10:1996;891-896.
15. Hajimohammadreza I., Probert A.W., Coughenour L.L., Borosky S.A., Marcoux F.W., Boxer P.A., Wang K.K. A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death. J. Neurosci. 15:1995;4093-4101.
16. 2+/calmodulin-dependent protein kinases. Annu. Rev. Biochem. 61:1992;559-601.
17. Hattori K., Angel P., Le Beau M.M., Karin M. Structure and chromosomal localization of the functional intronless human JUN protooncogene. Proc. Natl. Acad. Sci. U.S.A. 85:1988;9148-9152.
18. Haydar T.F., Kuan C.Y., Flavell R.A., Rakic P. The role of cell death in regulating the size and shape of the mammalian forebrain. Cereb. Cortex. 9:1999;621-626.
19. Izquierdo L.A., Barros D.M., Ardenghi P.G., Pereira P., Rodrigues C., Choi H., Medina J.H., Izquierdo I. Different hippocampal molecular requirements for short- and long-term retrieval of one-trial avoidance learning. Behav. Brain Res. 111:2000;93-98.
20. Jeon S.H., Kim Y.S., Bae C.D., Park J.B. Activation of JNK and p38 in rat hippocampus after kainic acid induced seizure. Exp. Mol. Med. 32:2000;227-230.
21. Kaminska B., Filipkowski R.K., Zurkowska G., Lason W., Przewlocki R., Kaczmarek L. Dynamic changes in the composition of the AP-1 transcription factor DNA-binding activity in rat brain following kainate-induced seizures and cell death. Eur. J. Neurosci. 6:1994;1558-1566.
22. Kim Y.H., Choi S.S., Lee J.K., Won J.S., Choi M.R., Suh H.W. Possible roles of JNK pathway in the regulation of hippocampal proenkephalin and immediate early gene expression induced by kainic acid. Mol. Cells. 11:2001;144-150.
23. Kitayama T., Ogita K., Yoneda Y. Sustained potentiation of AP1 DNA binding is not always associated with neuronal death following systemic administration of kainic acid in murine hippocampus. Neurochem. Int. 35:1999;453-462.
24. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:1996;312-318.
25. Lamph W.W., Wamsley P., Sassone-Corsi P., Verma I.M. Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature. 334:1988;629-631.
26. Laursen S.E., Belknap J.K. Intracerebroventricular injections in mice. Some methodological refinements. J. Pharmacol. Methods. 16:1986;355-357.
27. Le Gal La Salle G. Long-lasting and sequential increase of c-fos oncoprotein expression in kainic acid-induced status epilepticus. Neurosci. Lett. 88:1988;127-130.
28. Mielke K., Brecht S., Dorst A., Herdegen T. Activity and expression of JNK1, p38 and ERK kinases, c-Jun N-terminal phosphorylation, and c-jun promoter binding in the adult rat brain following kainate-induced seizures. Neuroscience. 91:1999;471-483.
29. Mikati M.A., Holmes G.L., Chronopoulos A., Hyde P., Thurber S., Gatt A., Liu Z., Werner S., Stafstrom C.E. Phenobarbital modifies seizure-related brain injury in the developing brain. Ann. Neurol. 36:1994;425-433.
30. Murray K.D., Hayes V.Y., Gall C.M., Isackson P.J. Attenuation of the seizure-induced expression of BDNF mRNA in adult rat brain by an inhibitor of calcium/calmodulin-dependent protein kinases. Eur. J. Neurosci. 10:1998;377-387.
31. Nadler J.V. Kainic acid as a tool for the study of temporal lobe epilepsy. Life Sci. 29:1981;2031-2042.
32. Olney J.W., de Gubareff T. The fate of synaptic receptors in the kainate-lesioned striatum. Brain Res. 140:1978;340-343.
33. Pennypacker K.R., McMillian M.K., Douglass J., Hong J.S. Ontogeny of kainate-induced gene expression in rat hippocampus. J. Neurochem. 62:1994;438-444.
34. Pennypacker K.R., Walczack D., Thai L., Fannin R., Mason E., Douglass J., Hong J.S. Kainate-induced changes in opioid peptide gene and AP-1 protein expression in rat hippocampus. J. Neurochem. 60:1993;204-211.
35. Popovici T., Represa A., Barbin G., Beaudoin M., Ben-Ari Y. Effects of kainic acid-induced seizures and ischemia on c-fos-like proteins in rat brain. Brain Res. 536:1990;183-194.
36. Reid C.A., Bliss T.V. Learning about kainate receptors. Trends Pharmacol. Sci. 21:2000;159-160.
37. Ryder K., Lau L.F., Nathans D.A. Gene activated by growth factor is related to the oncogene v-jun. Proc. Natl. Acad. Sci. U.S.A. 85:1988;1487-1491.
38. Sperk G., Lassmann H., Baran H., Kish S.J., Seitelberger F., Hornykiewicz O. Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience. 10:1983;1301-1315.
39. Streit W.J., Walter S.A., Pennell N.A. Reactive microgliosis. Prog. Neurobiol. 57:1999;563-581.
40. Sutula T., Lauersdorf S., Lynch M., Jurgella C., Woodard A. Deficits in radial arm maze performance in kindled rats: evidence for long-lasting memory dysfunction induced by repeated brief seizures. J. Neurosci. 15:1995;8295-8301.
41. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76:1979;257-261.
42. Treisman R. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:1996;205-215.
43. Vreugdenhil E., Datson N., Engels B., de Jong J., van Koningsbruggen S., Schaaf M., de Kloet E.R. Kainate-elicited seizures induce mRNA encoding a CaMK-related peptide: a putative modulator of kinase activity in rat hippocampus. J. Neurobiol. 39:1999;41-50.
44. Won J.S., Im Y.B., Kim Y.H., Song D.K., Huh S.O., Suh H.W. The modulatory role of nitric oxide in the regulation of proenkephalin and prodynorphin gene expressions induced by kainic acid in rat hippocampus. Brain Res. Mol. Brain Res. 56:1998;76-83.
45. Won J.S., Kim Y.H., Song D.K., Suh H.W. The effect of cycloheximide on the regulation of proenkephalin and prodynorphin gene expression induced by kainic acid in rat hippocampus. Mol. Brain Res. 47:1997;303-310.
46. Won J.S., Song D.K., Huh S.O., Kim Y.H., Suh H.W. Effect of melatonin on the regulation of proenkephalin and prodynorphin mRNA levels induced by kainic acid in the rat hippocampus. Hippocampus. 10:2000;236-243.
47. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
48. Xu K., Thornalley P.J. Signal transduction activated by the cancer chemopreventive isothiocyanates: cleavage of BID protein, tyrosine phosphorylation and activation of JNK. Br. J. Cancer. 84:2001;670-673.
49. Yan J.J., Cho J.Y., Kim H.S., Kim K.L., Jung J.S., Huh S.O., Suh H.W., Kim Y.H., Song D.K. Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br. J. Pharmacol. 133:2001;89-96.
50. Yu R., Jiao J.-J., Duh J.-L., Tan T.-H., Kong A.-N.T. Phenethyl isothiocyanate, a natural chemopreventive agent, activates c-Jun N-terminal kinase-1. Cancer Res. 56:1996;2954-2959.
51. Zagulska-Szymczak S., Filipkowski R.K., Kaczmarek L. Kainate-induced genes in the hippocampus: lessons from expression patterns. Neurochem. Int. 38:2001;485-501.
52. Zerial M., Toschi L., Ryseck R.P., Schuermann M., Muller R., Bravo R. The product of a novel growth factor activated gene, fos B, interact with JUN proteins enhancing their DNA binding activity. EMBO J. 8:1989;805-813.